0001731122-24-000425.txt : 20240313 0001731122-24-000425.hdr.sgml : 20240313 20240313155048 ACCESSION NUMBER: 0001731122-24-000425 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarsh Simon CENTRAL INDEX KEY: 0001943931 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38758 FILM NUMBER: 24745852 MAIL ADDRESS: STREET 1: 201 E. FIFTH STREET SUITE 1900 CITY: CINCINNATI STATE: OH ZIP: 45202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RENOVARO INC. CENTRAL INDEX KEY: 0001527728 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452259340 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 45 39179840 MAIL ADDRESS: STREET 1: CENTURY CITY MEDICAL PLAZA STREET 2: 2080 CENTURY CITY EAST CITY: SUITE 906 LOS ANGELES STATE: CA ZIP: 90067 FORMER COMPANY: FORMER CONFORMED NAME: RENOVARO BIOSCIENCES INC. DATE OF NAME CHANGE: 20230807 FORMER COMPANY: FORMER CONFORMED NAME: Enochian Biosciences Inc. DATE OF NAME CHANGE: 20230804 FORMER COMPANY: FORMER CONFORMED NAME: Renovaro Biosciences Inc. DATE OF NAME CHANGE: 20230802 4 1 ownership.xml X0508 4 2024-03-11 0 0001527728 RENOVARO INC. RENB 0001943931 Tarsh Simon C/O RENOVARO INC. 2080 CENTURY PARK E, SUITE 906 LOS ANGELES CA 90067 0 1 0 0 Interim CFO 0 Option to purchase shares of common stock 2.98 2024-03-11 4 A 0 10000 0 A 2034-03-11 Common Stock 10000 10000 D This option vests upon the termination of the Consulting Agreement effective March 11, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC so long that a replacement CFO is hired as of such date. /s/ Simon Tarsh 2024-03-13